Evidence map›Paper›PMID 41675512›Full record

ArticleQuantitative biology (Beijing, China)2025

Identifying early warning signals of cancer formation.

Chong Yu, Wenbo Li, Xiaona Fang, Jin Wang

Abstract read
In one paragraph

Article in Quantitative biology (Beijing, China), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Identifying early warning signals of cancer formation.Quantitative biology (Beijing, China) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chong YuState Key Laboratory of Electroanalytical Chemistry Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun China.ORCID https://orcid.org/0000-0003-1289-8578
Wenbo LiState Key Laboratory of Electroanalytical Chemistry Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun China.
Xiaona FangDepartment of Chemistry Northeast Normal University Changchun China.
Jin WangJoint Research Centre on Medicine the Affiliated Xiangshan Hospital of Wenzhou Medical University Ningbo China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is increasingly clear that cancer is a complex systemic disease and one of the most fatal diseases in humans. Complex systems, including cancer, exhibit critical transitions in which the system abruptly shifts from one state to another. However, predicting these critical transitions is difficult as the system may show little change before the tipping point is reached. Models for predicting cancer are generally not accurate enough to reliably predict where these critical transitions will occur. Additionally, there is often a gap between theoretical results and clinical practice. To address these issues, we conducted a study using gastric cancer as a representative to reveal the tipping point of cancer and develop a feasible method for clinical monitoring. We used gene regulatory networks and a landscape framework to quantify the formation of gastric cancer. Since the dissipation cost of cancer cells is different from that of normal cells, we calculated the entropy product rate (EPR) and mean flux to quantify the thermodynamic cost and dynamical driving force in predicting critical transitions of cancer, which can serve as early warning signals. Both the EPR and mean flux change sharply near the point when the cancer state is about to emerge and/or the normal state is about to disappear. Moreover, the peak or sharp upward trends of the signals occur much earlier than critical slowdown and flickering frequency. These significant variations can be used as early warning signals for cancer. To further explore early warning signals in clinical and experimental trials, we calculated the difference in cross correlations (Δ

Indexed as

cancer early warning signalsentropy production ratefluxgene regulatory networklandscapetime irreversibility

Identifiers

PMID41675512
PMCPMC12806070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.